Medicinal cannabis disclosure and reasons for non-disclosure in New Zealand

Loading...
Thumbnail Image

DOI

Open Access Location

Journal Title

Journal ISSN

Volume Title

Publisher

Sage Pu

Rights

CC BY 4.0
(c) the author/s 2026

Abstract

Aims: This study investigates demographic predictors of medicinal cannabis (MC) disclosures and non-disclosures in various contexts. Methods: 1,742 respondents from a large-scale, online survey in New Zealand, analysed through logistic regression models. Results: MC prescription holders and individuals with diagnoses were more likely to disclose MC use across all settings, while Asians were less likely. Māori were less likely to disclose for fear of police, whereas women perceived social stigma against women using cannabis. Pacific Peoples were more likely to disclose to employers. Respondents with prior drug testing experience or treating neurological or pain conditions were more likely to disclose in health settings. Respondents treating mental health were more likely to disclose to government services. Conclusion: MC disclosures are influenced by institutional contexts, perceived prejudices, and past experiences. Fear of judgement or consequences in workplaces and health settings are barriers to disclosure, highlighting the need for more supportive practices.

Description

Keywords

Citation

Withanarachchie V, Wilkins C, Parker K, Rychert M. (2026). Medicinal Cannabis Disclosure and Reasons for Non-disclosure in New Zealand. Journal of Drug Issues. 0. 0.

Collections

Endorsement

Review

Supplemented By

Referenced By

Creative Commons license

Except where otherwised noted, this item's license is described as CC BY 4.0